Two Sigma Investments, LP Ab Cellera Biologics Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 2,533,635 shares of ABCL stock, worth $6.99 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,533,635

Previous 2,061,356 22.91%

Holding current value

$6.99 Million

Previous $6.1 Million 7.56%

% of portfolio

0.02%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.39 - $3.49 $1.13 Million - $1.65 Million	472,279 Added 22.91%	2,533,635 $6.56 Million
Q2 2024 Aug 14, 2024	BUY	$2.73 - $4.73 $1.58 Million - $2.75 Million	580,441 Added 39.19%	2,061,356 $6.1 Million
Q1 2024 May 15, 2024	BUY	$4.29 - $5.97 $1.77 Million - $2.46 Million	411,677 Added 38.5%	1,480,915 $6.71 Million
Q4 2023 Feb 14, 2024	SELL	$3.91 - $5.93 $501,394 - $760,427	-128,234 Reduced 10.71%	1,069,238 $6.11 Million
Q3 2023 Nov 14, 2023	BUY	$4.6 - $7.95 $617,743 - $1.07 Million	134,292 Added 12.63%	1,197,472 $5.51 Million
Q2 2023 Aug 14, 2023	BUY	$5.66 - $7.59 $1.7 Million - $2.28 Million	300,834 Added 39.46%	1,063,180 $6.87 Million
Q1 2023 May 15, 2023	SELL	$7.31 - $11.18 $1.45 Million - $2.22 Million	-198,366 Reduced 20.65%	762,346 $5.75 Million
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $2.27 Million - $3.48 Million	-239,826 Reduced 19.98%	960,712 $9.73 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $4.35 Million - $6.47 Million	472,616 Added 64.93%	1,200,538 $11.9 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $1.33 Million - $2.47 Million	231,938 Added 46.76%	727,922 $7.75 Million
Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $146,335 - $277,370	-19,616 Reduced 3.8%	495,984 $4.84 Million
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $5.61 Million - $7.65 Million	431,500 Added 513.08%	515,600 $7.37 Million
Q3 2021 Nov 15, 2021	SELL	$14.85 - $21.34 $4.35 Million - $6.26 Million	-293,116 Reduced 77.71%	84,100 $1.69 Million
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $5.37 Million - $9.09 Million	265,931 Added 238.96%	377,216 $8.3 Million
Q1 2021 May 17, 2021	BUY	$23.29 - $53.2 $2.59 Million - $5.92 Million	111,285 New	111,285 $3.78 Million

Others Institutions Holding ABCL

# of Institutions

153

Shares Held

109M

Call Options Held

153K

Put Options Held

194K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Ab Cellera Biologics Inc. Transaction History